Pembrolizumab Overview, Dosage, How to Take, Side Effects and Pregnancy

Pembrolizumab is the generic name for the trade drug name Keytruda. Pembrolizumab is used to treat certain types of cancers (such as head/neck/skin/bladder/urinary tract cancer, non-small cell lung cancer, Hodgkin lymphoma). It works by changing the action of your own immune system, directing it to attack cancer cells. Pembrolizumab belongs to a class of drugs known as monoclonal antibodies.

Pembrolizumab dosing information. Receive this medication exactly as prescribed by your doctor.

  • The recommended dose of Keytruda (pembrolizumab) for the treatment of melanoma is 2 mg/kg over 30-minute infusion every 3 weeks.
  • The recommended dose of Keytruda (pembrolizumab) for the treatment of non-small cell lung cancer is 200 mg over 30-minute infusion every 3 weeks.
  • The recommended dose of Keytruda (pembrolizumab) for the treatment of patients with recurrent or advanced head and neck cancer is 200 mg over 30-minute infusion every 3 weeks.